298 Radiosurgical Management of Trigeminal Neuralgia in Multiple Sclerosis: Impact of Dose on Pain Relief and Clinical Outcomes

View at publisher Summarise with VIRAT
Authors: Andrés M. Alvarez-Pinzon, José Valerio, Guillermo de Jesús Aguirre Vera, Aizik L. Wolf
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Trigeminal neuralgia (TN) in patients with multiple sclerosis (MS) is a debilitating condition often resistant to medical therapy. Stereotactic radiosurgery (SRS) provides a minimally invasive alternative, but the optimal dosing strategy remains controversial, especially in demyelinating disease. METHODS: We conducted a retrospective multicenter analysis of MS patients with TN treated with Gamma Knife SRS from 2010 to 2025. Patients were stratified by prescription dose: ≤80 Gy, 85–90 Gy, and ≥95 Gy. Clinical outcomes included Barrow Neurological institute (BNI) pain scores, duration of pain relief, recurrence rates, and incidence of sensory complications. Median follow-up was 36 months. RESULTS: A total of 176 patients were included. At 12 months, complete or near-complete pain relief (BNI I–II) was observed in 76% of patients receiving ≥90 Gy, compared to 51% in the ≤80 Gy group (p < 0.01). Median time to pain recurrence was longer in the ≥90 Gy group (18.2 months) than in the ≤80 Gy group (10.7 months). Facial numbness occurred more frequently in patients receiving ≥95 Gy (27%) than those receiving ≤80 Gy (9%, p = 0.03). No serious cranial nerve deficits were reported. CONCLUSIONS: Higher radiosurgical doses improve short-term pain control and extend time to recurrence in MS-related TN but are associated with increased sensory side effects. an intermediate dosing range of 85–90 Gy may offer an optimal balance between efficacy and safety. Further prospective studies are warranted to refine dosing strategies for this challenging patient population.

Fields of Study & Subjects

Trigeminal Neuralgia and Treatments Pain Management and Treatment Meningioma and schwannoma management

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
75–75
Publication date
26 March 2026
Language
EN